Icecure Medical Ltd. cash flow statement

In fiscal 2025, Icecure Medical Ltd.'s operations generated −$14.6m of cash; it spent $36,000 on capital projects, leaving free cash flow of −$14.6m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Icecure Medical Ltd.: cash flow statement, annual
Fiscal year	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash from operations	−2	−4	−13	−14	−13	−13	−15
Depreciation and amortisation	0	0	0	0	0	0	0
Stock-based pay	0	0	0	2	1	1	1
Capital spending	0	0	1	1	0	0	0
Free cash flow	−2	−4	−13	−15	−13	−13	−15
Free cash flow after stock pay	−2	−4	−13	−17	−14	−14	−16
Shares issued	3	6	15	14	—	9	—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: CNSY vs ICCM ICCM vs INBS BMRA vs ICCM ICCM vs VNRX

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Icecure Medical Ltd.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Icecure Medical Ltd.